Related Experiment Video

Updated: May 3, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

10.5K

[Patient adapted valve selection: biological vs. mechanical heart valve replacement in aortic valve diseases]

S Brose1, R Autschbach, M Engel

  • 1Klinik für Thorax-, Herz- und Gefäßchirurgie, Klinikum RWTH Aachen, Pauwelstr. 30, 52074, Aachen, Germany, Sbrose@klinikum.rwth-aachen.de.

Zeitschrift Fur Kardiologie
|January 22, 2014
PubMed

Insights

For aortic valve replacement, biological prostheses are recommended for patients over 65 due to durability and anticoagulation risks. Further research is needed on stentless options.

Area of Science:

  • Cardiovascular Surgery
  • Biomaterials Science

Context:

  • Aortic valve disease is a common indication for cardiac surgery.
  • Heart valve prostheses include mechanical and biological options (xenografts, homografts).
  • Balancing prosthesis durability and anticoagulation risks is crucial.

Purpose:

  • To review indications for aortic valve stenosis and regurgitation surgery.
  • To compare the advantages and disadvantages of mechanical versus biological heart valve prostheses.
  • To present less common techniques like aortic valve reconstruction.

Summary:

  • Biological prostheses offer 12-15 years of durability, making them suitable for patients aged 65+ to mitigate anticoagulation risks.
  • Mechanical prostheses require lifelong anticoagulation, posing bleeding risks that increase with age.
  • Stentless biological prostheses are an emerging option, but long-term data are pending.

Impact:

  • Informs clinical decision-making for aortic valve replacement strategies.
  • Highlights the trade-offs between prosthesis types for patient outcomes.
  • Guides future research into improved heart valve technologies.

More Related Videos

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves11:12

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

13.1K
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

2.7K

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.6K
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
14.9K